Otolaryngology Coding Alert

READER QUESTIONS:

The Right Times for You to Report 94060 and 94640

Question: My ENT sometimes performs pre- and post-treatment pulmonary function tests (PFTs). How should we report these?


California Subscriber
Answer: If your ENT performs a bronchospasm evaluation to determine the patient's responsiveness to treatment, you should report 94060 (Bronchodilation responsiveness, spirometry as in 94010, pre- and post- bronchodilator administration). This code includes the spirometry measurements both pre- and post-bronchodilator administration.

Carriers do not consider the bronchodilator cost as part of the payment for 94060. Consequently, CPT
suggests that you report 99070 (Supplies and materials [except spectacles], provided by the physician over and above those usually included with the office visit or other services rendered [list drugs, trays, supplies or materials provided]) or the appropriate drug code.

If you report a drug code instead, you should choose a HCPCS code that identifies the specific drug and the amount the physician administered during the evaluation.

For example, if the physician uses Albuterol, you may select the most appropriate code (such as J7613, Albuterol, inhalation solution, administered through DME, unit dose, 1 mg), depending on the specific form and dose the physician administers.

But if the patient has an acute exacerbation of asthma (493.02, Extrinsic asthma; with [acute] exacerbation) and the physician must administer an inhaled bronchodilator, you should report 94640 (Pressurized or nonpressurized inhalation treatment for acute airway obstruction or for sputum induction for diagnostic purposes [e.g., with an aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (IPPB) device]) in addition to the appropriate J code representing the drug.

If the physician demonstrates and/or evaluates the patient administration of the drug, you should consider the demonstration/evaluation a component of 94640. You should not report the demonstration/
evaluation separately. Clinical and coding expertise for You Be the Coder and Reader Questions provided by Barbara J. Cobuzzi, MBA, CPC, CPC-H, CHBME, president of CRN Healthcare Solutions, a coding and reimbursement consulting firm in Shrewsbury, N.J.; and Charles F. Koopmann Jr., MD, MHSA, professor and associate chair at the University of Michigan's department of otolaryngology in Ann Arbor.
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Otolaryngology Coding Alert

View All